Thu.May 30, 2024

article thumbnail

Q&A: CVS Pharmacy Technician on Rhode Island Unionization Efforts

Drug Topics

Chris DesRochers, a pharmacy technician who works at a CVS in Wakefield, Rhode Island and is active in the recent organizing, discusses what motivated him and his coworkers to unionize.

530
530
article thumbnail

As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’

PharmaVoice

To lower drug prices, lawmakers are turning to the drug patent system to outlaw some common practices — but a former patent agency director says it’s the wrong way to go.

278
278
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Onyda XR, First and Only Liquid Nonstimulant for ADHD

Drug Topics

The drug will be available in pharmacies during the second half of 2024.

FDA 503
article thumbnail

A third U.S. farm worker infected with bird flu is the first to experience respiratory symptoms

STAT

A third human case of H5 bird flu tied to the ongoing U.S. outbreak in cattle has been detected in a farm worker in Michigan, state health authorities confirmed on Thursday. The unnamed individual worked on a dairy farm and was in close contact with infected cows, the state health department said in a statement. The farm involved is different from the one where an earlier human case was detected last week.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Approves Breyanzi to Treat Relapsed or Refractory Mantle Cell Lymphoma

Drug Topics

The approval of Lisocabtagene maraleucel (Breyanzi; liso-cel) was based on data from the TRANSCEND-NHL-001 study, in which the therapy showed rapid and durable response rates.

FDA 503
article thumbnail

Opinion: Stigma and the return of syphilis

STAT

Syphilis, one of the oldest infections known to humans, has returned to the U.S. at epidemic rates that have been climbing since 2001. In 2022, the last year with complete data, the highest number of infections were recorded in more than 70 years. It’s not yet clear why syphilis is spreading faster than other sexually transmitted infections. Recent shortages of single injection penicillin needed to treat this infection threatens to make matters worse.

145
145

More Trending

article thumbnail

COVID-19 vaccinations now ‘alarmingly low’ in Europe

pharmaphorum

COVID-19 vaccination rates have fallen precipitously in Europe and should be ramped up this autumn so they are at least in line with influenza vaccine uptake.

Vaccines 144
article thumbnail

CGM Roundup: Mental Health Impact, Landscape of Innovation, and More

Drug Topics

Catch up on important continuous glucose monitoring (CGM) news from the month of May.

307
307
article thumbnail

STAT+: Many docs who tweeted product endorsements also took money from manufacturers, analysis shows

STAT

Most physicians who endorsed a prescription drug or medical device on X — formerly known as Twitter — also received payments from the manufacturers of these products, according to a new analysis that highlights ongoing concerns about financial ties between doctors and industry. The study found 26 of 28 physicians, or 93%, received at least one payment, and the average was more than $27,400 for such things as food and beverages, speaking, consulting, or travel.

144
144
article thumbnail

Voices in Pharmacy: May 2024 Expert Interviews

Drug Topics

Check out these featured Drug Topics expert interviews from May 2024.

281
281
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Did Sarepta Therapeutics earn $4 billion from exon-skipping drugs that don’t work?

STAT

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here  to get it delivered every Thursday to their inbox. There is now a drug on the U.S. market, approved this week, called Bkemv. I’m not kidding. I wish I were. I’m flying to Chicago today for the ASCO meeting.

140
140
article thumbnail

Pharmacists Compare Experiences With Multiple Sclerosis at Large Academic Institutions, Small Private Practices

Pharmacy Times

Although resources were scarce for teams at smaller private practices, the pharmacists all agreed that patient care is always the priority.

article thumbnail

STAT+: Value-based payment is getting renewed attention. What it means isn’t getting any clearer

STAT

WASHINGTON — Nearly 20 years ago, policymakers had an epiphany: The health care system should pay for value instead of volume. Unfortunately, it’s now less clear than ever what value-based payment means, and whatever it is, it hasn’t lived up to the hype. Value-based payment, also known as value-based care, is getting renewed attention in Congress as doctors become increasingly distressed by a Medicare pay system that does not keep up with inflation.

Hospitals 136
article thumbnail

Going Back to the Basics: An Asthma Review

Pharmacy Times

A review of asthma guidelines, pharmacotherapy, and the role of the pharmacist.

139
139
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

How CVS is betting big on healthcare services 'locally delivered' on a national scale

Fierce Healthcare

WASHINGTON D.C. — CVS Health continues to invest heavily in healthcare delivery services with a focus on affordability, convenience and better access to primary care. | CVS Health continues to make investments in healthcare delivery services with a focus on affordability, convenience and better access to primary care.

134
134
article thumbnail

Carefully Consider Strategies When Switching Disease-Modifying Therapies for MS

Pharmacy Times

There has been a general shift toward earlier treatment and less tolerance for clinically silent disease activity.

139
139
article thumbnail

STAT+: Ultragenyx gene therapy for rare liver ailment succeeds in late-stage trial

STAT

Ultragenyx said Thursday afternoon that its gene therapy for a rare liver ailment, glycogen disease type 1A, succeeded in a Phase 3 trial, setting up a potential approval. Patients with GSD1a, as the condition is often known, have a genetic mutation that prevents them from adequately maintaining blood sugar levels. Once considered fatal, GSD1a can now be controlled with regular doses of cornstarch.

134
134
article thumbnail

Interview: Has Cybin hit the biggest breakthrough in 40 years to treat psychiatric disorders?

Outsourcing Pharma

In an intriguing interview with Cybinâs CEO, Doug Drysdale, OSP senior editor, Liza Laws found out how second-generation psychedelics could be the biggest breakthrough in psychiatry in 40 years.

133
133
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Study: New Tools Aid Development of Drugs for Respiratory Syncytial Virus

Pharmacy Times

Tools provide a safer testing option without using the viral proteins that cause infection.

132
132
article thumbnail

UnitedHealth projects shaky Medicaid redetermination aftermath

Fierce Healthcare

UnitedHealth is predicting an upcoming “disturbance” among its Medicaid programs as members continue to disenroll after the COVID-19 public health emergency. | UnitedHealth gave an overview of areas in which the insurer can improve upon, how Medicaid redeterminations will affect the company and thoughts on OptumRx.

Insurance 131
article thumbnail

FDA Approves Lisocabtagene Maraleucel for Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Pharmacy Times

Lisocabtagene maraleucel (Breyanzi; Bristol Myers Squibb) is a CD19-directed CAR T cell therapy that is delivered as a 1-time infusion.

FDA 132
article thumbnail

Mythic Therapeutics aims overcome one of ADC’s long-standing challenges

PharmaVoice

By developing ADCs that bind more directly to the target, Mythic Therapeutics believes its technology could deliver a step change for efficacy and safety.

130
130
article thumbnail

Data Show Disadvantaged Groups Have Significant Need for Lung Cancer Screening

Pharmacy Times

Individuals from a lower socioeconomic group showed more benefits from low-dose CT screening relating to lung cancer survival.

131
131
article thumbnail

Short reads, big impact: How genomics is revolutionising cancer research

pharmaphorum

Discover how genomics is transforming cancer research through the study of DNA, RNA, and ctDNA. Learn about the latest breakthroughs in the field in this insightful short read.

126
126
article thumbnail

Public Health Matters Video: Suicide Prevention and Reducing Mental Health Stigma

Pharmacy Times

Tune into this special episode of “Public Health Matters” to hear Emma White, the founder and president of the nonprofit organization Life Is Worth It, discuss her mental health journey and how she used it to educate adolescents, teenagers, and young adults on mental wellness.

130
130
article thumbnail

DOJ files objection to Steward Health Care's bankruptcy proceedings

Fierce Healthcare

The feds have raised an objection about Steward Health Care's planned bankruptcy proceedings, seeking additional time to investigate the health system's planned sale of its assets. | The feds have raised an objection about Steward Health Care's planned bankruptcy proceedings, seeking additional time to investigate the health system's planned sale of its assets.

120
120
article thumbnail

Mental Health Awareness Month: Reducing the Stigma Starts in Pharmacies

Pharmacy Times

Lenora Newsome, PD, president of the National Association of Boards of Pharmacy, explores how pharmacists can support mental health through private conversations, and educating about prescriptions.

123
123
article thumbnail

From Healing to Harm: The Unintended Consequences of Polypharmacy in Seniors

PharmD Live

Polypharmacy, or the concurrent use of at least five medications, can be essential for individuals with multiple chronic conditions. When medications are prescribed with clear therapeutic objectives, optimized to minimize adverse drug reactions (ADRs), and the patient adheres to the regimen, polypharmacy can be appropriate and beneficial. However, it often becomes excessive and hazardous when medications are unnecessary, fail to meet therapeutic goals, pose a high risk of ADRs, or when the patie

Hospitals 119
article thumbnail

US Congress passes bill to end Parkinson’s disease

pharmaphorum

The US Congress has passed the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for Alzheimer’s enacted in 2011

119
119
article thumbnail

STAT+: Novartis sues Maryland over the role of contract pharmacies in a U.S. drug discount program

STAT

Novartis has filed a lawsuit seeking to block a Maryland law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial U.S. government drug discount program. The drugmaker maintained that the state law , which goes into effect on July 1, improperly forces pharmaceutical companies to supply so-called contract pharmacies as part of the discount program known as 340B, according to the lawsuit filed in federal court.

Hospitals 116
article thumbnail

BioNTech, flush with $145M from CEPI, looks to expand mRNA vaccine production in Africa

Fierce Pharma

As various efforts to produce next-generation vaccines in Africa are being carried forward by the likes of the World Health Organization (WHO) and the Bill & Melinda Gates Foundation, BioNTech | Under an expansion of the partners’ existing deal, the Coalition for Epidemic Preparedness Innovations (CEPI) is committing up to $145 million to bolster BioNTech’s efforts to establish vaccine R&D and manufacturing capabilities at the German company’s facility in Kigali, Rwanda.

Vaccines 116
article thumbnail

Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. A big welcome to everyone coming to Chicago for ASCO this weekend. Say hi if you’re attending our  STAT event  on Friday night!

FDA 114
article thumbnail

First patient gets bowel cancer jab in NHS 'matchmaker' push

pharmaphorum

The first patient has received a BioNTech colorectal cancer vaccine as part of the NHS Cancer Vaccine Launch Pad (CVLP) 'matchmaker' service

Vaccines 111